Literature DB >> 16537172

Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram.

Binglan Yu1, Zunchang Liu, Thomas Ming Swi Chang.   

Abstract

There has been considerable discussions on why some types of haemoglobin-based blood substitutes increase vasoactivity whereas a very few others do not. In this study, we prepare four different types of PolyHb each containing different percentage of tetrameric hemoglobin using glutaraldehyde crosslinking and characterized to ensure that they all have the same oxygen affinity. Thus the preparations are prepared from the same chemical method and have the same oxygen affinity. We infused these in the form of 1/6 volume toploading into anesthetized rats to simulate the use of blood substitutes in surgery. Mean arterial pressure (MAP) increased immediately after injection of PolyHb containing 38% or 78% of tetrameric hemoglobin. However, there was no significant increase in blood pressure with the injection of PolyHb containing 16% or 0.4% tetrameric hemoglobin. In electrocardiogram (ECG) study, we observe that high percentage (78%) of tetrameric hemoglobin causes marked changes in ECG immediately after infusion. Injection of PolyHb containing 16% or 38% of tetrameric hemoglobin resulted in minimal elevation of the ST segment. Infusion of PolyHb containing 0.4% of tetrameric hemoglobin did not result in any changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537172     DOI: 10.1080/10731190600580223

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  8 in total

1.  Use of the labscale tangential flow diafiltrator to remove tetrameric hemoglobin from polyhemoglobin, purify hemolysate, and concentrate polyhemoglobin.

Authors:  Ada Stefanescu; Thomas Ming Swi Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2009-02-18

Review 2.  Nanobiotechnology for hemoglobin-based blood substitutes.

Authors:  T M S Chang
Journal:  Crit Care Clin       Date:  2009-04       Impact factor: 3.598

3.  Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction.

Authors:  Pedro Cabrales; Guoyong Sun; Yipin Zhou; David R Harris; Amy G Tsai; Marcos Intaglietta; Andre F Palmer
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

4.  Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model.

Authors:  Bjorn Kyungsuck Song; William H Nugent; Paula F Moon-Massat; Roland N Pittman
Journal:  Microvasc Res       Date:  2014-07-18       Impact factor: 3.514

Review 5.  Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.

Authors:  Thomas Ming Swi Chang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Jul-Aug

Review 6.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

7.  Blood substitutes--the polyheme trials.

Authors:  Sameer S Apte
Journal:  Mcgill J Med       Date:  2008-01

8.  Resuscitation From Hemorrhagic Shock With Fresh and Stored Blood and Polymerized Hemoglobin.

Authors:  Alexander T Williams; Alfredo Lucas; Cynthia R Muller; Carlos Munoz; Crystal Bolden-Rush; Andre F Palmer; Pedro Cabrales
Journal:  Shock       Date:  2020-10       Impact factor: 3.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.